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Sample panels of SARS-CoV-2 cases were retrospectively whole-genome sequenced. In three individuals,
samples of upper and lower respiratory tract resulted in identical sequences suggesting virus stability
including the spike protein cleavage site. In a fourth case, low-level intra-host genomic evolution and a
unique 5-nucleotide deletion was observed.
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While SARS-CoV mainly affects the lower respiratory tract tissue,
SARS-CoV-2 replicates effectively in the nasopharynx leading to a
more efficient transmission of the virus (W€olfel et al., 2020). Irrespec-
tive of the severity of SARS-CoV-2 infection, the virus consistently
replicates in the upper and lower respiratory epithelia (Weiss et al.,
2020). Until now, sequence stability of SARS-CoV-2 in the upper and
lower respiratory tract (URT and LRT, respectively) is insufficient
explored. Therefore, sample panels comprising different clinical spec-
imen of lethal SARS-CoV-2 cases were retrospectively investigated
(Augsburg study (Schaller et al., 2020), Supplementary Table 1). After
decease, postmortem analyses were performed between April 6 and
May 13, 2020 (n = 13, Fig. 1A); samples were taken from different
sites of URT and LRT and were tested for SARS-CoV-2 RNA using RT-
qPCR (Supplementary Table 2). Selected samples were subsequently
used for high-throughput sequencing (HTS) to compare whole-
genome sequences, which originated from different specimens per
case (URT vs. LTR, Fig. 1A). HTS was performed with samples whenmore than one sample per case was available and/or the RT-qPCR
cycle threshold values were ≤25. Methods are described in the
Supplementary Methods.
With this rationale, 13 whole-genome SARS-CoV-2 sequences
were obtained. Four cases (AS-007, AS-011, AS-012, AS-015) were
represented by two to four sequences obtained from different clinical
samples. In two cases, all analyzed SARS-CoV-2 whole-genome
sequences obtained from one individual were identical, in particular
pharynx and/or trachea, bronchus, and pleura samples (cases marked
in blue and red, Fig. 1B). These individuals (AS-011, AS-012, as well as
AS-008 represented by only one sample) had been infected with the
same virus variant of SARS-CoV-2 lineage B.1.5 (Rambaut et al.,
2020). Sequences marked in yellow (AS-015) differ from the sequen-
ces of the blue/red/grey cluster and could be assigned to SARS-CoV-2
lineage B.1.1. The case with the most divergent sequences of the
study, in relation to the reference, is represented by the green-
marked samples, assigned to SARS-CoV-2 lineage B.40 (case AS-007).
The sequences show the closest relationship to sequences reported
from Jamaica and France (Supplementary Figure 1), and go back to an
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early in the pandemic until it was replaced by the more infectious
S-614G type (Korber et al., 2020). The sampling date of the green-
marked case AS-007 (April 2020) matches with the main circulation
period of this virus type. Furthermore, these S-614D type sequences
found in pharyngeal and pleura samples showed a 5-nucleotide (nt)
deletion in ORF8 (Fig. 1B), which leads to a truncation of 15 amino
acids when CTG can be used as an alternative start codon, and intro-
duces a frameshift (Fig. 1C). If no alternative start codon can be used,
the protein would be completely lost. Such a 5-nt deletion of ORF8
was not described before, i.e., it is not existing in any SARS-CoV-2
sequence submitted to NCBI so far (until March 12, 2021). In addition
to the deletion, we detected one transition (position 2492, Fig. 1B) in
the SARS-CoV-2 sequence of the pharynx sample compared with the
pleura sample. Single nucleotide variants (SNVs) were not detected
in any of the analyzed samples except sample 4032 (pharynx, green-
marked case AS-007). Here, we detected two SNVs, namely T9817C
(frequency 24.4%) and C12775T (frequency 12.7%; 0.53 strand bias
for both variants), that were both not found in the corresponding
pleura sample. Importantly, none of the sequences showed any
changes or SNVs in the SARS-CoV-2 spike protein cleavage site.
Intra-host variability during the course of COVID-19 was investi-
gated and compartmentalized virus replication was observed in for-
mer SARS-CoV-2 studies (Jary et al., 2020; Rueca et al., 2020).
However, neither significant differences regarding nucleotide diver-
sity and SNVs nor a compartment-specific pattern were detected
between samples from different respiratory compartments (Rueca
et al., 2020). Also in our study, not investigating the evolutionary pro-
cess during the disease but rather the result of potential intra-host
evolution in postmortem samples, we could not find any indication
that a specific adaptation to different compartments of the respira-
tory tract is necessary for efficient virus replication and severe dis-
ease. Despite the apparent stability, some single nucleotide changes
could be seen between samples from the upper and the lower respi-
ratory tract in one case. Our findings indicate some low-level intra-
host genomic evolution of the virus of this individual case but
depending on the tissue in which the virus replicated (pharynx) and
maybe the virus type. Avanzato and colleagues reported a prolonged
virus shedding by an immunocompromised individual with cancer
including a clear intra-host evolution of the SARS-CoV-2 virus during
the prolonged infection (Avanzato et al., 2020). The patient of the
green-marked case (AS-007) underwent a hospitalization period of
seven days until decease. The onset of typical COVID-19 symptoms
was six days before admission (Supplementary Table 3). No special
peculiarities during the course of disease possibly connected to
COVID-19 could be specified (Supplementary Table 4). The soon
decease might be due to the comorbidities, i.e., a malign lung tumor
in progressed stage (poorly differentiated adenocarcinoma stage 4)
besides atrial fibrillation, and aortic valve stenosis (Supplementary
Table 5). However, we cannot fully exclude a longer persistence of
the infection before clinical admission. With respect to the unique
ORF8 deletion detected in this patient, different deletions within the
SARS-CoV-2 ORF8 have been described before (Flower et al., 2021;
Pereira, 2020; Su et al., 2020). The accessory gene encoded by ORF8 is
suspected to have an important role in immune response of the host
(Flower et al., 2021; Weiss et al., 2020).
Despite the small patient cohort, our results do not indicate a
general necessity of tissue specific adaptation but rather an acci-
dental occurrence of SNVs; they also suggest stability of the
spike protein cleavage site within different compartments of
patient's respiratory tract. However, sequences of one individual
showed a unique deletion of ORF8 and additionally some
sequence differences between the URT and LRT sequences. This
might be a patient-induced effect due to poor health condition
of the individual. In addition, it can only be speculated whether
a longer-term replication of the virus could occur as in the caseof other described ORF8 deletions. Overall, based on the present
data with a limited sample size, this provides a hint and needs
to be proven in further cohort studies. Furthermore, the study
underlines the importance of whole-genome sequencing to
detect variants and to reveal intra-host evolution of the virus.
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Fig. 1. Overview of sampling, diagnostic methods used and results. (A) Cases subjected to autopsy; RT-qPCR was performed with several samples of 13 COVID-19 deceased (results
see Supplementary Table 2). SARS-CoV-2 whole-genome sequencing was performed for different samples of five marked cases. Respiratory tract was taken from pixabay (https://
pixabay.com/). (B) Documentation of nucleotide exchanges in SARS-CoV-2 genomes found in five different individuals. Numbers above represent the nucleotide position of the
exchange according to the reference SARS-CoV-2 isolate 2019_nCoV Muc IMB1 (first German case; accession number LR824570). Exchanges are marked in the color of the case. The
nucleotide in position 23415 represents the S-614 type (nucleotide G stands for S-614G; nucleotide A stands for S-614D). (C) The 5-nucleotide deletion in position 26955 results in
a frame shift in ORF8 (lower green-marked ORF8) in contrast to the ORF8 of the other cases with typical length. Light grey lines symbolize nucleotide sequences. The extended
insert shows the nucleotide deletion with translation into amino acids downstream the beginning of ORF8
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